Urine desmosine as a novel biomarker for bronchopulmonary dysplasia and post-prematurity respiratory disease in extremely preterm or low-birth-weight infants.
Katsuya HirataMasanori NishikawaMasatoshi NozakiHiroyuki KitajimaItaru YanagiharaKazuko WadaMasanori FujimuraPublished in: American journal of perinatology (2022)
Elevated urine desmosine/creatinine levels on the third postnatal week were associated with bubbly/cystic lungs on day 28 and PRD at 18 months of corrected age in EP or ELBW infants.